Johns Hopkins ABX Guide
Pivmecillinam
INDICATIONS
FDA
FDA
- FDA approved April 2024, but it is not yet available commercially.
- Treatment of female patients 18 years and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of urinary tract infections for susceptible pathogens
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 15, 2025
Citation
Auwaerter, Paul G, and Edina Avdic. "Pivmecillinam." Johns Hopkins ABX Guide, The Johns Hopkins University, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540665/all/Pivmecillinam.
Auwaerter PG, Avdic E. Pivmecillinam. Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540665/all/Pivmecillinam. Accessed February 28, 2025.
Auwaerter, P. G., & Avdic, E. (2025). Pivmecillinam. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540665/all/Pivmecillinam
Auwaerter PG, Avdic E. Pivmecillinam [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. [cited 2025 February 28]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540665/all/Pivmecillinam.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pivmecillinam
ID - 540665
A1 - Auwaerter,Paul,M.D.
AU - Avdic,Edina,Pharm.D.
Y1 - 2025/01/15/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540665/all/Pivmecillinam
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
